at://
/
app.bsky.feed.post
/
3mohcp2oax22b
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
PostEmbed
FDA Clears Sanofi’s Tzield as First Disease-Modifying Therapy for Stage 3 Type 1 Diabetes | iPharmaCenter
Sanofi has secured US regulatory clearance for Tzield as a treatment aimed at modifying disease progression in children recently diagnosed with stage 3 type 1 diabetes. The authorization marks the fir...
www.ipharmacenter.com